At the time of writing, GoodRx Holdings Inc [GDRX] stock is trading at $8.50, up 5.46%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GDRX shares have gain 10.25% over the last week, with a monthly amount glided 4.17%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
GoodRx Holdings Inc [NASDAQ: GDRX] stock has seen the most recent analyst activity on May 23, 2024, when RBC Capital Mkts upgraded its rating to a Outperform and also boosted its price target to $10 from $8. Previously, Raymond James upgraded its rating to Outperform on May 16, 2024, and kept the price target unchanged to $10. On April 10, 2024, upgrade upgraded it’s rating to Overweight but maintained its price target of $9 on the stock. Wells Fargo upgraded its rating to a Overweight and increased its price target to $10 on March 25, 2024. JP Morgan upgraded its rating to a Overweight and raised its price target to $10 on March 01, 2024. Leerink Partners started tracking with a Outperform rating for this stock on February 26, 2024, and assigned it a price target of $8. In a note dated January 02, 2024, BofA Securities downgraded an Underperform rating on this stock and revised its target price from $8 to $4.50.
For the past year, the stock price of GoodRx Holdings Inc fluctuated between $4.14 and $9.37. Currently, Wall Street analysts expect the stock to reach $14.57 within the next 12 months. GoodRx Holdings Inc [NASDAQ: GDRX] shares were valued at $8.50 at the most recent close of the market. An investor can expect a potential return of 71.41% based on the average GDRX price forecast.
Analyzing the GDRX fundamentals
According to GoodRx Holdings Inc [NASDAQ:GDRX], the company’s sales were 764.16M for trailing twelve months, which represents an 7.55% jump. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at -0.08%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.15 points at the first support level, and at 7.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.70, and for the 2nd resistance point, it is at 8.91.
Ratios To Look Out For
It is important to note that GoodRx Holdings Inc [NASDAQ:GDRX] has a current ratio of 6.29. As well, the Quick Ratio is 6.29, while the Cash Ratio is 4.58. Considering the valuation of this stock, the price to sales ratio is 4.17, the price to book ratio is 5.05.
Transactions by insiders
Recent insider trading involved Wagner Scott,, that happened on Nov 30 ’23 when 21652.0 shares were purchased., Wagner Scott completed a deal on Nov 29 ’23 to buy 26348.0 shares. Meanwhile, Wagner Scott bought 4157.0 shares on Nov 28 ’23.
